Table 3.
Cox proportional hazard ratio (HR) a and 95% confidence interval (95% CI) of prostate cancer-specific mortality according to one unit increase in baseline BMI
| HR (95% CI) | P-value | |
|---|---|---|
| All prostate cancer | 1.09 (1.05–1.14) | <0.0001 |
| Controlling for aspirin and beta-carotene | 1.09 (1.05–1.14) | <0.0001 |
| Excluding any deaths occurred first 5 years | 1.10 (1.05–1.15) | <0.0001 |
| Excluding current smokers | 1.11 (1.06–1.16) | <0.0001 |
| Excluding diabetes | 1.09 (1.05–1.14) | <0.0001 |
| Excluding non-Caucasians | 1.11 (1.05–1.16) | <0.0001 |
| Excluding stage T1 | 1.10 (1.05–1.15) | <0.0001 |
| Excluding metastasis (N1/M1) | 1.08 (1.02–1.13) | 0.0039 |
a
All adjusted for age at diagnosis, smoking status at baseline (past smoking for the analysis excluding current smokers) and time interval from baseline to prostate cancer diagnosis.